5-Methoxytryptamine

Chemical compound
5-Methoxytryptamine
Identifiers
  • 2-(5-Methoxy-1H-indol-3-yl)ethanamine
CAS Number
  • 608-07-1 checkY
PubChem CID
  • 1833
IUPHAR/BPS
  • 107
ChemSpider
  • 1767 checkY
UNII
  • 3VMW6141KC
KEGG
  • C05659 checkY
ChEBI
  • CHEBI:2089 checkY
ChEMBL
  • ChEMBL8165 checkY
CompTox Dashboard (EPA)
  • DTXSID60209638 Edit this at Wikidata
ECHA InfoCard100.009.231 Edit this at Wikidata
Chemical and physical data
FormulaC11H14N2O
Molar mass190.246 g·mol−1
3D model (JSmol)
  • Interactive image
  • O(c1cc2c(cc1)[nH]cc2CCN)C
InChI
  • InChI=1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 checkY
  • Key:JTEJPPKMYBDEMY-UHFFFAOYSA-N checkY
  (verify)

5-Methoxytryptamine (5-MT), also known as mexamine, is a tryptamine derivative closely related to the neurotransmitters serotonin and melatonin. 5-MT has been shown to occur naturally in the body in low levels.[1] It is biosynthesized via the deacetylation of melatonin in the pineal gland.[1]

5-MT acts as a full agonist at the 5-HT1, 5-HT2, 5-HT4, 5-HT6, and 5-HT7 receptors.[2][3][4][5][6][7][8] It has no affinity for the 5-HT3 receptor and its affinity for the 5-HT1E receptor is very weak in comparison to the other 5-HT1 receptors.[5][9] Its affinity for the 5-HT5A receptor is unknown.

Indorenate

Measured affinity for some receptors (incomplete list):

  • 5-HT1B receptors (Ki = 35 nM) [10]
  • 5-HT1D receptors (Ki = 7.3 nM)[11]
  • 5-HT1E receptors (Ki = 3151 nM)[12]
  • 5-HT1F receptors (Ki = 1166 nM)[13]
  • 5-HT2A receptors (Ki = 295 nM)[14]
  • 5-HT2B receptors (Ki = 16.4 nM)[15]
  • 5-HT2C receptors (Ki = 52.48 nM) [16]
  • 5-HT4 receptors (Ki = 501.18 nM)[17]
  • 5-HT6 receptors (Ki = 69.18 nM)[18]
  • 5-HT7 receptors (Ki = 5.01 nM)[19]

See also

References

  1. ^ a b Galzin AM, Eon MT, Esnaud H, Lee CR, Pévet P, Langer SZ (1988). "Day-night rhythm of 5-methoxytryptamine biosynthesis in the pineal gland of the golden hamster (Mesocricetus auratus)". J. Endocrinol. 118 (3): 389–397. doi:10.1677/joe.0.1180389. PMID 2460575.
  2. ^ Wu PH, Gurevich N, Carlen PL (1988). "Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine". Neurosci. Lett. 86 (1): 72–76. doi:10.1016/0304-3940(88)90185-1. PMID 2966313. S2CID 21620262.
  3. ^ Yamada J, Sugimoto Y, Yoshikawa T, Horisaka K (1997). "Hyperglycemia induced by the 5-HT receptor agonist, 5-methoxytryptamine, in rats: involvement of the peripheral 5-HT2A receptor". Eur J Pharmacol. 323 (2–3): 235–240. doi:10.1016/S0014-2999(97)00029-0. PMID 9128844.
  4. ^ Amemiya N, Hatta S, Takemura H, Ohshika H (1996). "Characterization of the contractile response induced by 5-methoxytryptamine in rat stomach fundus strips". Eur J Pharmacol. 318 (2–3): 403–409. doi:10.1016/S0014-2999(96)00777-7. PMID 9016931.
  5. ^ a b Craig DA, Eglen RM, Walsh LK, Perkins LA, Whiting RL, Clarke DE (1990). "5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum". Naunyn-Schmiedeberg's Arch Pharmacol. 342 (1): 9–16. doi:10.1007/bf00178965. PMID 2402303. S2CID 24743785.
  6. ^ Boess FG, Monsma Jr FJ, Carolo C, Meyer V, Rudler A, Zwingelstein C, Sleight AJ (1997). "Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells". Neuropharmacology. 36 (4–5): 713–720. doi:10.1016/S0028-3908(97)00019-1. PMID 9225298. S2CID 41813873.
  7. ^ Hemedah M, Coupar IM, Mitchelson FJ (1999). "[3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum". Br J Pharmacol. 126 (1): 179–188. doi:10.1038/sj.bjp.0702293. PMC 1565797. PMID 10051134.
  8. ^ Glennon RA, Dukat M, Westkaemper RB (2000-01-01). "Serotonin Receptor Subtypes and Ligands". American College of Neurophyscopharmacology. Archived from the original on 21 April 2008. Retrieved 2008-04-11.
  9. ^ Roth, Brian (2006). The serotonin receptors. Humana Press. p. 133. ISBN 978-1-58829-568-2.
  10. ^ S. Nigra / Domenech T, et al., 1997
  11. ^ Cortex / PEROUTKA ET AL., 1989
  12. ^ Cloned / ZGOMBICK JM, ET AL., 1992
  13. ^ Cloned / Adham N, et al., 1992
  14. ^ Cortex / HOYER ET AL., 1987
  15. ^ Cortex / WAINSCOTT DB, ET AL., 1996
  16. ^ Cloned / BONHAUS DW, ET AL., 1997
  17. ^ Caudate / ANSANAY H, ET AL.,1996
  18. ^ Cloned / Hirst WD, et.al.,2003
  19. ^ Cloned / BOESS FG, ET AL., 1994
  • v
  • t
  • e
Amino acid-derived
Major excitatory /
inhibitory systems
Glutamate system
GABA system
Glycine system
GHB system
Biogenic amines
Monoamines
Trace amines
Others
Neuropeptides
  • See here instead.
Lipid-derived
Endocannabinoids
Neurosteroids
  • See here instead.
Nucleobase-derived
Nucleosides
Adenosine system
Vitamin-derived
Miscellaneous
Cholinergic system
Gasotransmitters
Candidates
  • v
  • t
  • e
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Dopaminergics
  • Melatonergics
  • Monoamine reuptake inhibitors and releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
  • v
  • t
  • e
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins
  • v
  • t
  • e


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e